IBIT 97-day bearish forecast — Nov 1, 2026

  • Bias: Bearish
  • Timeframe: 97 days (made Nov 1, 2026, target date Feb 5, 2027)
  • Price at analysis: $43.36
  • Price target: $40.50
  • Expected range: $34.50 – $48.00
  • Result: Pending — graded after the close on Feb 5, 2027

Get a free AI analysis of IBIT today

IBIT technical analysis chart

Analysis

TECHNICAL INDICATORS

  • RSI (14): 36.64, down sharply from about 47 on Oct 29 and 50 on Oct 28. It is approaching oversold (<30) but not there yet. Momentum is clearly deteriorating after a rejection near $47.84. [Bearish]
  • 20 EMA: Not provided. The EMA 50 at $44.94 is the nearest reference. Price at $43.36 has closed below it, and it is now overhead resistance. The EMA 50 has also just started to roll over (44.94 vs 45.00 the prior day). [Bearish]
  • MACD: Line -0.188 vs signal 0.208, a fresh bearish crossover on Oct 30. The line has declined for about 12 sessions from +1.0 and has now crossed below zero. The histogram is negative and widening. [Bearish]
  • Bollinger Bands (20): Upper $48.67, lower $44.23. Price at $43.36 is below the lower band, which is a breakdown or oversold extension. The bands are moderately wide after the Aug-Sep rally. A close below the lower band in a −DI-led move often shows continuation, but it can also trigger a mean-reversion bounce. [Bearish]
  • CMF (20): -0.009, inside the neutral ±0.05 zone. It has faded from +0.14 in mid-October and has hovered around zero since. Buying pressure is gone, but there is no heavy distribution yet. [Neutral]
  • ADX (14): 19.1 with +DI 17.8 and −DI 35.7. ADX is low, so the trend is weak, but −DI has jumped well above +DI, which means sellers are taking control. If ADX rises from here, it would confirm a developing downtrend. [Weak Trend, Bearish Direction]
  • Volume: 119.91M on the latest bar, the largest spike in recent months, on a sharp red candle (-5.1%). That is high-volume selling and suggests a distribution or capitulation-style drop. [Bearish]

Other moving averages: price is below the EMA 50 ($44.94), EMA 200 ($44.08), SMA 50D ($45.89) and VWAP ($43.87). It is above the SMA 200D ($41.48), so the long-term structure is not yet broken. The SMA 50D is flattening just above the EMA 200, so a bearish cross may be forming.

DIVERGENCES & TRENDS

  • There is no clear bullish divergence. RSI and MACD are making lower highs in line with price, which confirms the weakness.
  • Price made a lower high at $47.84 (Oct 21), compared with about $49 in early September. That is a sequence of lower highs, with MACD fading from its August peak above 1.0.
  • Price lost the EMA 200 ($44.08) and VWAP ($43.87) on a closing basis with a -$2.35 single-day drop.
  • DI crossover: −DI is now double +DI (35.7 vs 17.8), a bearish control signal.
  • The MACD bearish crossover and the drop below the zero line are fresh and unfavorable.
  • The SMA 200D at $41.48 is rising slowly and is the key long-term support. Below it lie the Aug base near $36-37 and the Jun lows near $33-34.
  • The SMA 50D ($45.89) is still above the SMA 200D, so there is no death cross. The gap is narrowing quickly, which is a risk.

CHART PATTERNS

  • Since the Aug-Sep spike, the chart shows a roughly $43-$49 range that is now breaking at the bottom. It resembles a Bearish Double Top / Triple Top structure (peaks near $49 in early Sep and $47.8 in late Oct), with a possible neckline around $43-44. A decisive break would project a measured move of roughly $5-6 down, to about $38-39.
  • A Bearish Pennant/Flag fit is plausible after the Aug rally was followed by a drifting consolidation. The breakdown projects toward the Aug base near $36-37.
  • The main counterargument is a larger base. The Jun-Aug lows near $33-35 were followed by a strong recovery, and price is still above the rising SMA 200D, so a bounce within a broad range is possible.

POTENTIAL SCENARIOS

  • Scenario 1: Bearish Breakdown Toward the Range Low — The high-volume drop below the EMA 200, VWAP and lower Bollinger Band continues. −DI dominance and the MACD cross-down lead to a test of the SMA 200D and the double-top measured move. Trigger: daily close below $42.50 and failure to reclaim $44.08. Target: $38.50, with an extension to $36.50. Invalidation: weekly close back above $46.00. (50% probability)
  • Scenario 2: Neutral Range Chop and Recovery — Price stabilizes near the SMA 200D around $41.5-$42.5, RSI resets below 35, and it oscillates between $40 and $46 with a slow grind back toward the EMAs. Trigger: bullish RSI divergence or a low-volume hold above $41.50. Target: $43-$45. Invalidation: close below $40.50 or above $46.50. (25% probability)
  • Scenario 3: Bullish Reversal Bounce — The oversold bounce becomes a trend resumption, price reclaims the EMA 50/SMA 50D, and the move retests the $47-$49 highs. Trigger: close above $45.90 on rising volume with a MACD re-cross. Target: $48.50. Invalidation: close below $41.50. (25% probability)

PRICE TARGETS

Over a 97-day horizon, the bearish momentum shift (high-volume breakdown, MACD cross, −DI dominance) outweighs the cooling in the oversold bounce case, and the base case targets a move toward the SMA 200D and below.

  • Target Price: $40.50 (97 days)
  • Expected Range: $34.50 to $48.00. The width is $13.50, about 31% of the current price. This is slightly above the 18-30% guidance for 61-180 days, which fits IBIT's high volatility, with ATR of $1.25 at about 2.9% daily.
  • Key Levels: Support at $41.48 (SMA 200D), then $36.50. Resistance at $44.08 (EMA 200), then $45.89 (SMA 50D).

OVERALL BIAS

OVERALL BIAS: BEARISH - Price broke below the EMA 200, VWAP and lower Bollinger Band on the heaviest volume in months. MACD crossed bearishly, and −DI (35.7) is roughly double +DI (17.8), with RSI weakening toward 30. The main support is the rising SMA 200D near $41.48, and the measured move points to about $38-40.

This is educational analysis and not financial advice.

More IBIT predictions

See every IBIT prediction and its track record

Get a free AI analysis of IBIT today

AI-generated technical analysis for education only — not financial advice.